Latest Nature Medicine Stories
Caltech researchers develop quick, low-cost, and portable microchip for immune monitoring and clinical applications.
A study by researchers at Children's Hospital Boston and collaborators at other institutions has provided new insights into the means by which bone cells produce new bone in response to mechanical stresses, such as exercise.
Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments.
A team of researchers have found that pre-existing malaria prevents secondary infection by another Plasmodium strain, the parasite responsible for malaria, by restricting iron availability in the liver of the host.
University of Cincinnati (UC) researchers have determined why a certain class of diabetes drugs leads to weight gain and have found that the molecular system involved (PPAR-Î³ found in the brain) is also triggered by consumption of high-fat foods.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease (COPD) and several other lung conditions.
Using sinus tissue removed during surgery at University of Wisconsin Hospital and Clinics, researchers at the University of Wisconsin-Madison have managed to grow a recently discovered species of human rhinovirus (HRV), the most frequent cause of the common cold, in culture.
PHILADELPHIA, April 3, 2011 /PRNewswire-USNewswire/ -- Promising new research reveals a potentially highly effective treatment for heterotopic ossification (HO), a painful and often debilitating abnormal buildup of bone tissue.
Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment.
Nature Medicine is a peer-reviewed academic journal established in 1995 and published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. As with other Nature journals, this periodical has no external Editorial Board, with editorial decisions being made by an in-house team. Nature Medicine publishes research articles, reviews, news and commentary pieces. Topics include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. Research...